Throughout this review, we have explored the genetic landscape of melanoma, highlighting the importance of mutations in key genes such as BRAF, NRAS, and KIT, as well as the relevance of epigenetic modifications and interactions with the tumor microenvironment. The gene discussed is BRAF; the disease is melanoma.